Recent Finacing
Recent Raise
Autem Therapeutics develops AutEMsys, a bioelectric oncology platform delivering personalized amplitude‑modulated electromagnetic frequencies to treat hepatocellular carcinoma and other solid tumors, pursuing FDA IDE and clinical trials.
